52 related articles for article (PubMed ID: 22525091)
1. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
[TBL] [Abstract][Full Text] [Related]
2. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
Xing EM; Knox VW; O'Donnell PA; Sikura T; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Jun; 109(2):183-93. PubMed ID: 23628461
[TBL] [Abstract][Full Text] [Related]
3. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.
Daly TM; Vogler C; Levy B; Haskins ME; Sands MS
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2296-300. PubMed ID: 10051635
[TBL] [Abstract][Full Text] [Related]
4. Self-complementary AAV vector therapy for treating corneal cloudiness of mucopolysaccharidosis type VII (MPS VII).
Venkatakrishnan J; Yuan Y; Zhang J; Yu Y; Hu YC; Kao WW
Ocul Surf; 2024 Apr; 32():39-47. PubMed ID: 38218582
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidosis VII in a Cat Caused by 2 Adjacent Missense Mutations in the GUSB Gene.
Wang P; Sorenson J; Strickland S; Mingus C; Haskins ME; Giger U
J Vet Intern Med; 2015; 29(4):1022-8. PubMed ID: 26118695
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular degeneration and locomotor deficit in a
Bar S; Prasad M; Datta R
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30459155
[TBL] [Abstract][Full Text] [Related]
7. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs.
Lau YK; Peck SH; Arginteanu T; Wu M; Lin M; Shore EM; Klein PS; Casal ML; Smith LJ
Bone; 2022 Jan; 154():116237. PubMed ID: 34695616
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for lysosomal storage diseases: Current clinical trial prospects.
Kido J; Sugawara K; Nakamura K
Front Genet; 2023; 14():1064924. PubMed ID: 36713078
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Emerging Treatment Strategies for Mucopolysaccharidosis VII (Sly Syndrome).
Poswar FO; Henriques Nehm J; Kubaski F; Poletto E; Giugliani R
Ther Clin Risk Manag; 2022; 18():1143-1155. PubMed ID: 36578769
[TBL] [Abstract][Full Text] [Related]
10. The beta-glucuronidase intracisternal A particle insertion model results in similar overall MPSVII phenotype as the single base deletion model when on the same C57BL/6J mouse background.
Devanney SC; Gibney JM; Le Prell CG; Wronski TJ; Aguirre JI; Mcdoom I; Heldermon CD
Mol Genet Metab Rep; 2021 Jun; 27():100727. PubMed ID: 33604242
[TBL] [Abstract][Full Text] [Related]
11. Altered IHH signaling contributes to reduced chondrocyte proliferation in the growth plate of MPS VII mice.
Jiang Z; Derrick-Roberts ALK; Byers S
Mol Genet Metab Rep; 2020 Dec; 25():100668. PubMed ID: 33117654
[TBL] [Abstract][Full Text] [Related]
12.
Wada M; Shimada Y; Iizuka S; Ishii N; Hiraki H; Tachibana T; Maeda K; Saito M; Arakawa S; Ishimoto T; Nakano T; Ida H; Ohashi T; Kobayashi H
Mol Ther Methods Clin Dev; 2020 Dec; 19():261-274. PubMed ID: 33102618
[TBL] [Abstract][Full Text] [Related]
13. Failures of Endochondral Ossification in the Mucopolysaccharidoses.
Jiang Z; Byers S; Casal ML; Smith LJ
Curr Osteoporos Rep; 2020 Dec; 18(6):759-773. PubMed ID: 33064251
[TBL] [Abstract][Full Text] [Related]
14. Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.
van den Broek BTA; van Doorn J; Hegeman CV; Nierkens S; Lindemans CA; Verhoeven-Duif N; Boelens JJ; van Hasselt PM
Blood Adv; 2020 Jun; 4(12):2837-2849. PubMed ID: 32574368
[TBL] [Abstract][Full Text] [Related]
15. New Prospects for Restoring Skeletal Growth in Mucopolysaccharidoses.
Espiner EA; Prickett TCR
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32152627
[No Abstract] [Full Text] [Related]
16. Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone.
Kunihiro AG; Luis PB; Brickey JA; Frye JB; Chow HS; Schneider C; Funk JL
J Nat Prod; 2019 Mar; 82(3):500-509. PubMed ID: 30794412
[TBL] [Abstract][Full Text] [Related]
17. Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice.
Derrick-Roberts ALK; Jackson MR; Pyragius CE; Byers S
Diseases; 2017 Feb; 5(1):. PubMed ID: 28933358
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.
Peck SH; Casal ML; Malhotra NR; Ficicioglu C; Smith LJ
Mol Genet Metab; 2016 Aug; 118(4):232-43. PubMed ID: 27296532
[TBL] [Abstract][Full Text] [Related]
19. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
